AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 132 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51,870 | -16.1% | 45,500 | -31.9% | 0.00% | – |
| Q2 2023 | $61,815 | +280877.3% | 66,798 | +67.8% | 0.00% | – |
| Q1 2023 | $22 | -99.7% | 39,800 | +49.1% | 0.00% | – |
| Q3 2022 | $8,000 | -89.0% | 26,700 | -16.4% | 0.00% | – |
| Q4 2021 | $73,000 | -65.4% | 31,936 | -41.5% | 0.00% | – |
| Q2 2021 | $211,000 | -33.6% | 54,600 | -46.7% | 0.00% | – |
| Q1 2021 | $318,000 | +25.7% | 102,371 | +20.9% | 0.00% | – |
| Q4 2020 | $253,000 | +82.0% | 84,687 | +45.3% | 0.00% | – |
| Q3 2020 | $139,000 | -9.2% | 58,292 | +384.4% | 0.00% | – |
| Q2 2020 | $153,000 | -54.9% | 12,034 | -71.8% | 0.00% | – |
| Q1 2020 | $339,000 | -33.7% | 42,647 | -45.2% | 0.00% | – |
| Q4 2019 | $511,000 | +116.5% | 77,762 | +36.1% | 0.00% | – |
| Q3 2019 | $236,000 | -35.5% | 57,132 | -24.4% | 0.00% | – |
| Q2 2019 | $366,000 | -25.8% | 75,549 | +25.5% | 0.00% | -100.0% |
| Q1 2019 | $493,000 | +45.0% | 60,200 | -4.6% | 0.00% | +100.0% |
| Q4 2018 | $340,000 | – | 63,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,031,283 | $95,485,000 | 5.72% |
| GREAT POINT PARTNERS LLC | 3,510,073 | $47,667,000 | 3.81% |
| Logos Global Management LP | 1,200,000 | $16,296,000 | 3.26% |
| DAFNA Capital Management LLC | 762,666 | $10,357,000 | 2.99% |
| Baupost Group | 15,000,000 | $203,700,000 | 2.54% |
| Nantahala Capital Management | 6,101,111 | $82,853,000 | 2.50% |
| Abrams Capital Management | 5,656,462 | $76,815,000 | 2.48% |
| Novo Holdings A/S | 1,987,506 | $26,990,000 | 1.74% |
| Stanley-Laman Group, Ltd. | 316,933 | $4,304,000 | 1.04% |
| Integral Health Asset Management, LLC | 250,000 | $3,395,000 | 1.02% |